Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Esophagogastric Junction.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05858736
What this trial is testing

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more
OncoC4, Inc. 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05476796
What this trial is testing

Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

Who this might be right for
Gastric AdenocarcinomaEsophagus AdenocarcinomaGastroesophageal Junction Adenocarcinoma
UNICANCER 118
Early research (Phase 1)Ended earlyNCT02283359
What this trial is testing

Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
H. Lee Moffitt Cancer Center and Research Institute 3
Early research (Phase 1)Study completedNCT03894618
What this trial is testing

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more
Shattuck Labs, Inc. 49
Testing effectiveness (Phase 2)UnknownNCT04813523
What this trial is testing

Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma

Who this might be right for
Adenocarcinoma of Esophagogastric JunctionNeoadjuvant ChemotherapyPembrolizumab
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT02202759
What this trial is testing

MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the StomachGastroesophageal Junction Expressing Guanylyl Cyclase C
Millennium Pharmaceuticals, Inc. 38
Testing effectiveness (Phase 2)Study completedNCT02082210
What this trial is testing

Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

Who this might be right for
Advanced CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+3 more
Eli Lilly and Company 97
Testing effectiveness (Phase 2)Study completedNCT00858338
What this trial is testing

Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer

Who this might be right for
Gastric CancerStomach Cancer
NYU Langone Health 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06118658
What this trial is testing

Chemotherapy Sequential Tislelizumab After Radical Resection in Patients With dMMR/MSI-H or POLE/POLD1 Mutations

Who this might be right for
GastricColorectal Adenocarcinoma
China Medical University, China 30
Testing effectiveness (Phase 2)Study completedNCT02539225
What this trial is testing

Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Metastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Eli Lilly and Company 191
Testing effectiveness (Phase 2)Active Not RecruitingNCT06423885
What this trial is testing

BL-M07D1 Combination Therapy in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 64
Large-scale testing (Phase 3)Ended earlyNCT05111626
What this trial is testing

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Amgen 515
Not applicableNot Yet RecruitingNCT07625735
What this trial is testing

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Who this might be right for
Gastric / Gastroesophageal Junction AdenocarcinomaMismatch Repair Deficient or MSI-High Solid TumorsLymph Node Metastasis+1 more
Shanghai Zhongshan Hospital 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT07115485
What this trial is testing

Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
Shanghai Henlius Biotech 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07408609
What this trial is testing

Perioperative Chemotherapy With Low-Dose Radiotherapy and Tislelizumab for Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
Jiangsu Cancer Institute & Hospital 114
Early research (Phase 1)Active Not RecruitingNCT04391049
What this trial is testing

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Who this might be right for
Advanced Esophageal AdenocarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage II Esophageal Adenocarcinoma AJCC v8+30 more
NRG Oncology 16
Testing effectiveness (Phase 2)Study completedNCT04208958
What this trial is testing

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerMelanomaGastric Cancer+2 more
Vedanta Biosciences, Inc. 56
Large-scale testing (Phase 3)Looking for participantsNCT07673887
What this trial is testing

ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc. 570
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07621484
What this trial is testing

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

Who this might be right for
Locally Advanced Gastric CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Shanghai Changzheng Hospital 48
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Next Page